Natural and complementary therapies for substance use disorder

Current Opinion in Psychiatry

Volumn 18, Issue 3, 2005, Pages 271-276

  Dean, Angela J ^a,b  

^a MATER HOSPITAL   (Australia)

^b Kids in Mind Research   (Australia)

Author keywords

Addiction; Complementary therapies; Drug dependence; Herbal medicine; Substance use disorders

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALPHA TOCOPHEROL; AMPHETAMINE DERIVATIVE; ANTIDEPRESSANT AGENT; CYNARA SCOLYMUS EXTRACT; CYTOCHROME P450 3A4; DAIDZEIN; DRUG METABOLIZING ENZYME; EPHEDRINE; GINKGO BILOBA EXTRACT; GLYCOPROTEIN P; HYPERFORIN; HYPERICUM PERFORATUM EXTRACT; LI 120; LIV 52; MAGNESIUM; MAGNESIUM ASPARTATE; METHADONE; MORPHINE; NICOTINE; OPIATE ANTAGONIST; OPUNTIA FICUS INDICIA EXTRACT; ORAL CONTRACEPTIVE AGENT; PAPAVER RHOEAS EXTRACT; PASSIFLORA INCARNATA EXTRACT; PHOSPHATIDYLCHOLINE; PLANT EXTRACT; PROTEINASE INHIBITOR; PUERARIA LOBATA EXTRACT; PUERARIN; ROSMARINUS OFFICINALIS EXTRACT; SALVIA MILTIORRHIZA EXTRACT; SEROTONIN AGONIST; SILYMARIN; UNCLASSIFIED DRUG; VALERIAN;

ACUPUNCTURE; ADULT; ALCOHOL INTOXICATION; ALCOHOL LIVER DISEASE; ALCOHOL WITHDRAWAL; ALTERNATIVE MEDICINE; ANOREXIA; ARTICHOKE; AWARENESS; BABOON; CLINICAL TRIAL; COCAINE DEPENDENCE; EPHEDRA SINICA; EVIDENCE BASED MEDICINE; HANGOVER; HUMAN; HYPERICUM PERFORATUM; LIVER INJURY; METHADONE TREATMENT; MOUSE; NAUSEA; NONHUMAN; OPUNTIA; PAPAVER; PAPAVER RHOEAS; PASSION FRUIT; PSYCHOSIS; PSYCHOSOCIAL CARE; PUERARIA; PUERARIA LOBATA; RAT; REVIEW; ROSEMARY; SAFETY; SALVIA MILTIORRHIZA; SILYBUM MARIANUM; SMOKING CESSATION; SUBSTANCE ABUSE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; WITHDRAWAL SYNDROME; XEROSTOMIA;

EID: 17844367845     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.yco.0000165597.06176.71     Document Type: Review

References (54)

1. Manheimer E, Anderson BJ, Stein MD. Use and assessment of complementary and alternative therapies by intravenous drug users. Am J Drug Alcohol Abuse 2003; 29:401-413.
2. Rosenberg H, Melville J, McLean PC. Nonpharmacological harm-reduction interventions in British substance-misuse services. Addict Behav 2004; 29:1225-1229.
3. Rosenberg H, Phillips KT. Acceptability and availability of harm-reduction interventions for drug abuse in American substance abuse treatment agencies. Psychol Addict Behav 2003; 17:203-210.
4. Brunetti G, Serra S, Vacca G, et al. IDN 5082, a standardized extract of Salvia miltiorrhiza, delays acquisition of alcohol drinking behavior in rats. J Ethnopharmacol 2003; 85:93-97.
5. Vacca G, Colombo G, Brunetti G, et al. Reducing effect of Salvia miltiorrhiza extracts on alcohol intake: influence of vehicle. Phytother Res 2003; 17:537-541.
6. Serra S, Vacca G, Tumatis S, et al. Anti-relapse properties of IDN, 5082, a standardized extract of Salvia miltiorrhiza, in alcohol-preferring rats. J Ethnopharmacol 2003; 88:249-252.
7. Keung WM. Anti-dipsotropic isoflavones: the potential therapeutic agents for alcohol dependence. Med Res Rev 2003; 23:669-696.
8. Rezvani AH, Overstreet DH, Perfumi M, Massi M. Plant derivatives in the treatment of alcohol dependency. Pharmacol Biochem Behav 2003; 75:593-606. A review of research into natural compounds in animal models of alcohol intake.
9. Overstreet DH, Keung WM, Rezvani AH, et al. Herbal remedies for alcoholism: promises and possible pitfalls. Alcohol Clin Exp Res 2003; 27:177-185.
10. Benlhabib E, Baker JI, Keyler DE, Singh AK. Kudzu root extract suppresses voluntary alcohol intake and alcohol withdrawal symptoms in P rats receiving free access to water and alcohol. J Med Food 2004; 7:168-179.
11. Benlhabib E, Baker JI, Keyler DE, Singh AK. Effects of purified puerarin on voluntary alcohol intake and alcohol withdrawal symptoms in P rats receiving free access to water and alcohol. J Med Food 2004; 7:180-186.
12. Shebek J, Rindone JP. A pilot study exploring the effect of kudzu root on the drinking habits of patients with chronic alcoholism. J Altern Complement Med 2000; 6:45-48.
13. Whiskey E, Werneke U, Taylor D. A systematic review and meta-analysis of Hypericum perforatum in depression: a comprehensive clinical review. Int Clin Psychopharmacol 2001; 16:239-252.
14. Gelenberg AJ, Shelton RC, Crits-Christoph P, et al. The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medication. J Clin Psychiatry 2004; 65:1114-1119.
15. 2 extract and opioid receptor antagonists act synergistically to reduce ethanol intake in alcohol-preferring rats. Alcohol Clin Exp Res 2003; 27:1554-1562.
16. Wright CW, Gott M, Grayson B, et al. Correlation of hyperforin content of Hypericum perforatum (St John's Wort) extracts with their effects on alcohol drinking in C57BL/6J mice: a preliminary study. J Psychopharmacol 2003; 17:403-408.
17. Butterweck V. Mechanism of action of St John's Wort in depression: what is known? CNS Drugs 2003; 17:539-562.
18. Mattick RP, Hall W. Are detoxification programmes effective? Lancet 1996; 347:97-100.
19. Becker B, Bock B, Carmona-Barros R. St John's Wort oral spray reduces withdrawal symptoms during quitting smoking. In: Society for Research on Nicotine and Tobacco 9th Annual Meeting; New Orleans, Louisiana; 19-22 February 2003.
20. Catania MA, Firenzuoli F, Crupi A, et al. Hypericum perforatum attenuates nicotine withdrawal signs in mice. Psychopharmacology (Berl) 2003; 169:186-189,
21. Akhondzadeh S, Kashani L, Mobaseri M, et al. Passionflower in the treatment of opiates withdrawal: a double-blind randomized controlled trial. J Clin Pharm Ther 2001; 26:369-373.
22. Garfinkel D, Zisapel N, Wainstein J, Laudon M. Facilitation of benzodiazepine discontinuation by melatonin: a new clinical approach. Arch Intern Med 1999; 159:2456-2460.
23. Zhdanova IV, Piotrovskaya VR. Melatonin treatment attenuates symptoms of acute nicotine withdrawal in humans. Pharmacol Biochem Behav 2000; 67:131-135.
24. Dhawan K. Drug/substance reversal effects of a novel tri-substituted benzoflavone moiety (BZF) isolated from Passiflora incarnata Linn: a brief perspective. Addict Biol 2003; 8:379-386.
25. Hosseinzadeh H, Nourbakhsh M. Effect of Rosmarinus officinalis L. aerial parts extract on morphine withdrawal syndrome in mice. Phytother Res 2003; 17:938-941.
26. Pourmotabbed A, Rostamian B, Manouchehri G, et al. Effects of Papaver rhoeas extract on the expression and development of morphine-dependence in mice. J Ethnopharmacol 2004; 95:431-435.
27. Berman AH, Lundberg U, Krook AL, Gyllenhammar C. Treating drug using prison inmates with auricular acupuncture: a randomized controlled trial. J Subst Abuse Treat 2004; 26:95-102. A controlled trial of acupuncture for substance use in a prison population.
28. Trumpler F, Oez S, Stahli P, et al. Acupuncture for alcohol withdrawal: a randomized controlled trial. Alcohol Alcohol 2003; 38:369-375. A controlled trial of auricular needle and laser acupuncture for alcohol withdrawal in inpatients.
29. Ernst E. Complementary therapies for addictions: not an alternative. Addiction 2002; 97:1491-1492.
30. White AR, Rampes H, Ernst E. Acupuncture for smoking cessation. Cochrane Database Syst Rev )2002; (2); CD000009.
31. Villano LM, White AR. Alternative therapies for tobacco dependence. Med Clin North Am 2004; 88:1607-1621. A narrative review of the clinical findings and research challenges for acupuncture in tobacco dependence.
32. Margolin A. Acupuncture for substance abuse. Curr Psychiatry Rep 2003; 5:333-339. A narrative review of the clinical findings and research challenges for acupuncture in substance dependence.
33. Otto KC. Acupuncture and substance abuse: a synopsis, with indications for further research. Am J Addict 2003; 12:43-51. A narrative review of the clinical findings and research challenges for acupuncture in substance dependence.
34. Wiese J, McPherson S, Odden MC, Shlipak MG. Effect of Opuntia ficus indica on symptoms of the alcohol hangover. Arch Intern Med 2004; 164:1334-1340. A randomized controlled trial of a new intervention for preventing alcohol hangover.
35. Pittler MH, White AR, Stevinson C, Ernst E. Effectiveness of artichoke extract in preventing alcohol-induced hangovers: a randomized controlled trial. CMAJ 2003; 169:1269-1273. A small randomized controlled trial of a new intervention for preventing alcohol hangover.
36. Kampman K, Majewska MD, Tourian K, et al. A pilot trial of piracetam and ginkgo biloba for the treatment of cocaine dependence. Addict Behav 2003; 28:437-448. A controlled trial examining ginkgo biloba as an adjunct to psychological intervention in cocaine dependent outpatients.
37. Margolin A, Kantak K, Copenhaver M, Avants SK. A preliminary, controlled investigation of magnesium L-aspartate hydrochloride for illicit cocaine and opiate use in methadone-maintained patients. J Addict Dis 2003; 22:49-61. A controlled trial examining magnesium supplementation as an adjunct treatment to methadone maintenance.
38. Saller R, Meier R, Brignoli R. The use of silymarin in the treatment of liver diseases. Drugs 2001; 61:2035-2063.
39. Lieber CS, Leo MA, Cao Q, et al. Silymarin retards the progression of alcohol-induced hepatic fibrosis in baboons. J Clin Gastroenterol 2003; 37:336-339. A controlled study in a primate model of alcohol dependence of the milk thistle derived compound, silymarin.
40. Mezey E, Potter JJ, Rennie-Tankersley L, et al. A randomized placebo controlled trial of vitamin E for alcoholic hepatitis. J Hepatol 2004; 40:40-46.
41. de Silva HA, Saparamadu PA, Thabrew MI, et al. Liv.52 in alcoholic liver disease: a prospective, controlled trial. J Ethnopharmacol 2003; 84:47-50.
42. Lieber CS, Weiss DG, Groszmann R, et al. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease. Alcohol Clin Exp Res 2003; 27:1765-1772.
43. Hammerness P, Basch E, Ulbricht C, et al. St John's Wort: a systematic review of adverse effects and drug interactions for the consultation psychiatrist. Psychosomatics 2003; 44:271-282. A thorough review of safety issues associated with St John's wort (Hypericum perforatum).
44. Piscitelli SC, Burstein AH, Chaitt D, et al. Indinavir concentrations and St John's Wort. Lancet 2000; 355:547-548.
45. Schwarz UI, Buschel B, Kirch W. Unwanted pregnancy on self-medication with St John's Wort despite hormonal contraception. Br J Clin Pharmacol 2003; 55:112-113.
46. Eich-Hochli D, Oppliger R, Golay KP, et al. Methadone maintenance treatment and St. John's Wort: a case report. Pharmacopsychiatry 2003; 36:35-37. A small but important pharmacokinetic study describing reductions in methadone serum concentrations after treatment with St John's wort (Hypericum perforatum).
47. Oesterheld JR, Armstrong SC, Cozza KL. Ecstasy: pharmacodynamic and pharmacokinetic interactions. Psychosomatics 2004; 45:84-87.
48. Dean AJ, Moses GM, Vernon JM. Suspected withdrawal syndrome after cessation of St. John's Wort [abstract]. Ann Pharmacother 2003; 37:150.
49. Maglione M, Miotto K, Iguchi M, et al. Psychiatric effects of ephedra use: an analysis of food and drug administration reports of adverse events. Am J Psychiatry 2005; 162:189-191.
50. Walton R, Manos GH. Psychosis related to ephedra-containing herbal supplement use. South Med J 2003; 96:718-720.
51. Levisky JA, Karch SB, Bowerman DL, et al. False-positive RIA for methamphetamine following ingestion of an Ephedra-derived herbal product. J Anal Toxicol 2003; 27:123-124.
52. Markowitz JS, Donovan JL, DeVane CL, Chavin KD. Common herbal supplements did not produce false-positive results on urine drug screens analyzed by enzyme immunoassay. J Anal Toxicol 2004; 28:272-273.
53. Ernst E, Sherman KJ. Is acupuncture a risk factor for hepatitis? Systematic review of epidemiological studies. J Gastroenterol Hepatol 2003; 18:1231-1236. This paper reviews epidemiological studies examining associations between hepatitis C and acupuncture.
54. Pittler MH, Ernst E. Systematic review: hepatotoxic events associated with herbal medicinal products. Aliment Pharmacol Ther 2003; 18:451-471. This paper reviews the existing literature describing hepatotoxicity or other adverse effects on liver function associated with use of particular herbal compounds.